CareMax, Inc. to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

CareMax, Inc. (NASDAQ: CMAX; CMAXW) announced participation by CEO Carlos de Solo and CFO Kevin Wirges in the Morgan Stanley 20^th Annual Global Healthcare Conference on September 14, 2022, at 12:55 pm ET. The event includes a live audio webcast accessible on CareMax's investor relations website. CareMax focuses on technology-enabled value-based care for seniors, managing chronic diseases through a comprehensive platform that provides healthcare and social services across the United States.

MIAMI--(BUSINESS WIRE)-- CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that Chief Executive Officer Carlos de Solo and Chief Financial Officer Kevin Wirges will participate in a fireside chat at the Morgan Stanley 20^th Annual Global Healthcare Conference on Wednesday, September 14, 2022, at 12:55 pm Eastern Time.

A live audio webcast and replay of the event will be available on CareMax’s investor relations website at ir.caremax.com.

About CareMax
CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors. CareMax operates medical centers that offer a comprehensive suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States. Learn more at www.caremax.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth and strategy, the effects of the restatement of the Company’s past financial statements and the filing of the Company’s periodic reports. Words such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "envision," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "pro-forma," "project," "seek," "should," "target," or "will," or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. These forward-looking statements reflect the Company’s expectations, plans or forecasts of future events and views as of the date of this press release. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.

Important risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, whether the Company’s pending acquisition of Steward Value-Based Care will close and the risks associated therewith, the impact of COVID-19 or any variant thereof on the Company's business and results of operation; the availability of sites for de novo centers and the costs of opening such de novo centers; changes in market or industry conditions, regulatory environment, competitive conditions, and receptivity to the Company's services; the Company's ability to continue its growth, including in new markets; changes in laws and regulations applicable to the Company's business, in particular with respect to Medicare Advantage and Medicaid; the Company's ability to maintain its relationships with health plans and other key payers; any delay, modification or cancellation of government contracts; the Company's future capital requirements and sources and uses of cash, including funds to satisfy its liquidity needs and the Company’s ability to comply with the covenants under its credit agreement; the Company's ability to recruit and retain qualified team members and independent physicians; and risks related to future acquisitions. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in the Company's reports filed with the SEC. All information provided in this press release is as of the date hereof, and the Company undertakes no duty to update or revise this information unless required by law, and forward-looking statements should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220908005152/en/

Investor Relations

Samantha Swerdlin

VP Investor Relations

(847) 924-8980

samantha.swerdlin@caremax.com

Media

Christine Bucan

(305) 542-8855

christine@thinkbsg.com

Source: CareMax, Inc.

FAQ

When will CareMax participate in the Morgan Stanley healthcare conference?

CareMax will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 14, 2022, at 12:55 pm ET.

Where can I access the live webcast of the CareMax event?

The live audio webcast can be accessed on CareMax’s investor relations website at ir.caremax.com.

What is CareMax's focus in the healthcare industry?

CareMax focuses on providing technology-enabled value-based care and chronic disease management for seniors.

Who are the executives participating in the CareMax conference?

CEO Carlos de Solo and CFO Kevin Wirges will participate in the conference.

What stock symbols are associated with CareMax?

CareMax trades under the stock symbols CMAX and CMAXW on NASDAQ.